Suppr超能文献

垂体腺瘤经蝶窦切除术后蝶鞍的CT检查

CT of the sella turcica after transsphenoidal resection of pituitary adenomas.

作者信息

Kaplan H C, Baker H L, Houser O W, Laws E R, Abboud C F, Scheithauer B W

出版信息

AJR Am J Roentgenol. 1985 Dec;145(6):1131-40. doi: 10.2214/ajr.145.6.1131.

Abstract

A retrospective review of 120 patients undergoing transsphenoidal surgery for pituitary adenomas revealed that computed tomography (CT) was less sensitive and less specific than hormonal methods in identifying residual functioning adenomas. However, CT was the only useful method of evaluating nonfunctioning tumors, including pseudo-prolactinomas. Enlargement of the pituitary stalk, when seen on preoperative CT, was 100% predictive of "cure" if the enlargement returned to normal size on a remote follow-up scan (n = 8) and was 100% predictive of residual tumor if the enlargement persisted or evolved (n = 8). Resolution of stalk displacement was the next most reliable predictor of cure (91%, n = 11), but persistent displacement was less reliable than abnormal intrasellar enhancement in predicting the presence of residual tumor (71%, n = 28, vs. 81%, n = 26). Enhancement in the postoperative sella by other than normal pituitary gland was presumed to be due to inflammation in 19% of patients. Inflammatory enhancement was observed in the presence of autograft and homograft muscle plugs and, unlike enhancement due to untreated tumors, was observed to decrease in size and intensity with time. Intrasellar enhancement was an unreliable criterion of success or failure in cases of microadenoma. All 14 patients with functioning adenomas and preoperative parasellar tumor extension had persistent tumor at postoperative evaluation. Of the 47 patients with resected functioning adenomas who had CT scans showing empty or partly empty sellas after operation, 22 (47%) had hormonally detectable residual tumor.

摘要

一项对120例因垂体腺瘤接受经蝶窦手术患者的回顾性研究显示,在识别残留的功能性腺瘤方面,计算机断层扫描(CT)的敏感性和特异性均低于激素检测方法。然而,CT是评估无功能性肿瘤(包括假性催乳素瘤)的唯一有用方法。术前CT显示垂体柄增粗时,如果在远期随访扫描中增粗恢复正常大小(n = 8),则100%预测“治愈”;如果增粗持续存在或进展(n = 8),则100%预测有残留肿瘤。垂体柄移位的消失是次最可靠的治愈预测指标(91%,n = 11),但在预测残留肿瘤的存在方面,持续移位不如鞍内异常强化可靠(71%,n = 28,对比81%,n = 26)。术后鞍内除正常垂体组织外的强化,19%的患者推测是由炎症引起。在存在自体移植和同种异体肌肉填塞物的情况下观察到炎症性强化,与未治疗肿瘤引起的强化不同,炎症性强化的大小和强度随时间减小。在微腺瘤病例中,鞍内强化是判断手术成功或失败的不可靠标准。所有14例有功能性腺瘤且术前鞍旁肿瘤侵犯的患者在术后评估时均有残留肿瘤。在47例接受手术切除的有功能性腺瘤且术后CT扫描显示蝶鞍空虚或部分空虚的患者中,22例(47%)有激素可检测到的残留肿瘤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验